Submitted by thewallstreetjournal7221 in health
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion so far, analysts say
Submitted by thewallstreetjournal7221 in health
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion so far, analysts say